Original Articles

An’s anorectal fumigation lotion for nuclear factor kappa-B pathway-targeted treatment of inflammatory mixed hemorrhoids

  • Dayong FENG ,
  • Ayue AN ,
  • Yuening FENG ,
  • Chunhui WANG ,
  • Zhiyong BAI ,
  • Qian WANG
Expand
  • 1 Department of Anorectal surgery, Wangjing Hospital, China Academy of Chinese Medical Sciences, Beijing 100102, China
    2 Department of surgery, the 305th Hospital of the Chinese People's Liberation Army, Beijing 100017, China
Dr AN Ayue, Department of surgery, the 305th Hospital of the Chinese People's Liberation Army, Beijing 100017, China. wangxistar@126.com,Telephone: +86-15711194303

Received date: 2024-07-16

  Accepted date: 2024-11-23

  Online published: 2025-07-25

Supported by

Science and Technology Innovation Project of the Chinese Academy of Traditional Chinese Medicine: Mechanism of An's Anorectal Fumigation Lotion in the Treatment of Inflammatory Mixed hemorrhoids based on Nuclear Factor Kappa-B Pathway(CI2021A02104)

Abstract

OBJECTIVE: To investigate the mechanism by which An’s anorectal fumigation lotion (AAFL) treats inflammatory mixed hemorrhoids.

METHODS: Eighty Sprague-Dawley rats, with an equal number of males and females, were randomly assigned to the following four groups: control, model, AAFL, and positive groups. Following hemorrhoid induction, hemorrhoidal tissues were collected from the rats for analysis. Pathological alterations in these tissues were examined via hematoxylin-eosin staining. Immun-ohistochemistry was used to detect inflammatory markers. The ultrastructural pathological changes in these tissues were observed by transmission electron microscopy. Reverse transcription-polymerase chain reaction and Western blotting were used to analyze the gene and protein expression of nuclear factor kappa-B (NF-κB) p65, inhibitor of kappa-B (IκB), inhibitor of NF-κB kinase (IκK-β), interleukin-1 beta (IL-1β), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α).

RESULTS: Compared with the control group, the rats in each treatment group showed general improvements in hemorrhoidal tissue pathology. The AAFL group showed increased IκB expression and decreased IL-1β, IL-6, TNF-α, NF-κB, p65, and IκK-β expressions.

CONCLUSION: AAFL can decrease the production of inflammatory markers by targeting the NF-κB pathway, resulting in improved pathological conditions in mixed hemorrhoids. Our findings will aid in the treatment of mixed hemorrhoids.

Cite this article

Dayong FENG , Ayue AN , Yuening FENG , Chunhui WANG , Zhiyong BAI , Qian WANG . An’s anorectal fumigation lotion for nuclear factor kappa-B pathway-targeted treatment of inflammatory mixed hemorrhoids[J]. Journal of Traditional Chinese Medicine, 2025 , 45(4) : 777 -785 . DOI: 10.19852/j.cnki.jtcm.2025.04.008

References

1. The Coloproctology Society of Chinese Association of Integrative Medicine. Chinese Guidelines for the Diagnosis and Treatment of Hemorrhoids (2020). Jie Zhi Chang Gang Men Wai Ke 2020; 26: 519-33.
2. Liang B, Gao JZ, Wang JD, Xu CH, Shi Z. An exploration on mechanisms of treatment of different diseases with the sametherapeutic method of the Shao-bei injection in treating rectal prolapse and mixed hemorrhoids based on network pharmacology. Zhong Yi Lin Chuang Yan Jiu 2022; 14: 13-8.
3. Feng YN, Wang Q, Feng DY, Wang CH, Bai ZY, An AY. Observation of the synergistic effect of An’s anorectal fumigation lotion on anal fistula surgery and postoperative recovery process. Zhong Guo Lin Chuang Yi Sheng Za Zhi 2020; 48: 1252-4.
4. Gong Y. Clinical and experimental research on the treatment of hemorrhoids with pulse electric Traditional Chinese Medicine ion introduction. Yunnan Zhong Yi Xue Yuan Xue Bao 2000; 23: 7-11.
5. Wang X, Wang CH, Wang JB, Bai ZY, An AY. Buyang Huanwu Tang combined with fuming-wash regent for sitz bath in the treatment of functional anorectal pain: efficacy observation. Zhong Guo Gang Chang Bing Za Zhi 2018; 38: 57-9.
6. Miao MS, Zhang MF, Tian S. Specification for the preparation of Chinese medicine hemorrhoid animal model. Zhong Yao Yao Li Yu Lin Chuang 2017; 33: 212-4.
7. MacKay DJ. Hemorrhoids and varicose veins: a review of treatment options. Altern Med Rev 2001; 6: 126-40.
8. Lohsiriwat V. Hemorrhoids: from basic pathophysiology to clinical management. World J Gastroenterol 2012; 18: 2009-17.
9. Ishiyama G, Nishidate T, Ishiyama Y, et al. Anal cushion lifting method is a novel radical management strategy for hemorrhoids that does not involve excision or cause postoperative anal complications. World J Gastrointest Surg 2015; 7: 273-8.
10. Kalkdijk J, Broens P, Ten Broek R, et al. Functional constipation in patients with hemorrhoids: a systematic review and Meta-analysis. Eur J Gastroenterol Hepatol 2022; 34: 813-22.
11. Mitchell PJ, Klarskov N, Hosker G, Lose G, Kiff ES. Anal acoustic reflectometry: a new technique for assessing anal sphincter function. Colorectal Dis 2010; 12: 692-7.
12. Margetis N. Pathophysiology of internal hemorrhoids. Ann Gastroentero 2019; 32: 264-72.
13. Bhoyar PS, Deshpande SA, Amle PN, Gomkale KM, Agrawal RN, Sunchuwar UP. Hemorrhoids: a review on herbal treatments and models for pharmacological evaluation. Int J Pharm Sci Rev Res 2020; 63: 160-7.
14. Cheng SD. Huang Di Nei Jing. Shanghai: Shanghai Science and Technology Publishing House, 1984: 91.
15. Elmslie RE, Dow SW, Ogilvie GK. Interleukins: biological properties and therapeutic potential. J Vet Intern Med 1991; 5: 283-93.
16. Viatour P, Merville MP, Bours V, Chariot A. Phosphorylation of NF-kappa B and Ikappa B proteins: implications in cancer and inflammation. Trends Biochem Sci 2005; 30: 43-52.
17. Lawrence T. The nuclear factor NF-kappa B pathway in inflammation. Cold Spring Harb Perspect Biol 2009; 1: a001651.
18. Capece D, Verzella D, Flati I, Arboretto P, Cornice J, Franzoso G. NF-κB: blending metabolism, immunity, and inflammation. Trends Immunol 2022; 43: 757-75.
Outlines

/